Clinical Trial Update: Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update showing completion of Phase 1 and Phase 2 studies of NPC-08 for newly diagnosed malignant glioma and recurrent glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Malignant Glioma

Drugs mentioned

• NPC-08

Snippet

Sponsor: Nobelpharma | Conditions: Malignant Glioma | Phase 1, Phase 2 | Status: COMPLETED